scholarly article | Q13442814 |
P50 | author | Jørgen Skov Jensen | Q37376597 |
P2093 | author name string | Falk L | |
Fredlund H | |||
P2860 | cites work | The role of Mycoplasma genitalium in non-gonococcal urethritis | Q24679772 |
Association between Mycoplasma genitalium and acute endometritis | Q28206155 | ||
Mycoplasma genitalium: a cause of male urethritis? | Q33934453 | ||
Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations | Q34055986 | ||
Mycoplasma genitalium -- an up-date | Q34115532 | ||
Detection of Mycoplasma genitalium by PCR amplification of the 16S rRNA gene | Q34747682 | ||
Associations between Mycoplasma genitalium, Chlamydia trachomatis, and pelvic inflammatory disease | Q35530456 | ||
Tetracycline treatment does not eradicate Mycoplasma genitalium | Q35530803 | ||
Symptomatic urethritis is more prevalent in men infected with Mycoplasma genitalium than with Chlamydia trachomatis | Q35531416 | ||
Etiology of urethral discharge in West Africa: the role of Mycoplasma genitalium and Trichomonas vaginalis | Q36934108 | ||
Polymerase chain reaction for detection of Mycoplasma genitalium in clinical samples | Q37229009 | ||
Genital chlamydial infections: epidemiology and reproductive sequelae | Q37730584 | ||
Mucopurulent cervicitis and Mycoplasma genitalium | Q37870078 | ||
Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. | Q37870096 | ||
Chlamydia-like symptoms can have another etiology. Mycoplasma genitalium--an important and common sexually transmitted disease | Q37870423 | ||
High prevalence of Mycoplasma genitalium in the lower genitourinary tract of women attending a sexually transmitted disease clinic in Paris, France | Q37871877 | ||
Serological investigation of Mycoplasma genitalium in infertile women | Q37873556 | ||
Role of Mycoplasma genitalium and Ureaplasma urealyticum in acute and chronic nongonococcal urethritis | Q37874585 | ||
The association of Mycoplasma hominis, Ureaplasma urealyticum and Mycoplasma genitalium with bacterial vaginosis: observations on heterosexual women and their male partners | Q37876187 | ||
Occurrence and treatment of Mycoplasma genitalium in patients visiting STD clinics in Sweden | Q37876488 | ||
Mycoplasma genitalium in non-gonococcal urethritis--a study in Swedish male STD patients | Q37876493 | ||
Mucopurulent cervicitis--the ignored counterpart in women of urethritis in men. | Q37905519 | ||
Diagnosis and Etiology of Nongonococcal Urethritis | Q37911139 | ||
The vaginal pH and leucocyte/epithelial cell ratio vary during normal menstrual cycles | Q41770783 | ||
A NEWLY DISCOVERED MYCOPLASMA IN THE HUMAN UROGENITAL TRACT | Q56057554 | ||
Gonorrhea | Q56094139 | ||
Detection and Quantification of Mycoplasma genitalium in Male Patients with Urethritis | Q58004109 | ||
P433 | issue | 1 | |
P921 | main subject | Chlamydia trachomatis | Q131065 |
urethritis | Q1122485 | ||
Mycoplasma genitalium | Q1930909 | ||
P304 | page(s) | 73-78 | |
P577 | publication date | 2005-02-01 | |
P1433 | published in | Sexually Transmitted Infections | Q7458852 |
P1476 | title | Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection | |
P478 | volume | 81 |
Q37840512 | 2015 UK National Guideline on the management of non-gonococcal urethritis. |
Q38922868 | 2016 European guideline on Mycoplasma genitalium infections |
Q47140812 | A Systematic Review of Mycoplasma and Ureaplasma in Urogynaecology |
Q37006345 | A serological study of the role of Mycoplasma genitalium in pelvic inflammatory disease and ectopic pregnancy |
Q37191589 | Analysis identifying common and distinct sequences among Texas clinical strains of Mycoplasma genitalium |
Q38772340 | Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium |
Q36321280 | Association of Mycoplasma genitalium with infertility in North Indian women |
Q43414119 | Asymptomatic non-specific urethritis: making observations but drawing the wrong conclusion |
Q38949023 | Background review for the 2016 European guideline on Mycoplasma genitalium infections |
Q54614037 | Cervicitis and genitourinary symptoms in women culture positive for Mycoplasma genitalium. |
Q37844311 | Cervicitis of unknown etiology |
Q35137772 | Chlamydia trachomatis and Mycoplasma genitalium plasma antibodies in relation to epithelial ovarian tumors |
Q37849099 | Chlamydia trachomatis, Mycoplasma genitalium and Ureaplasma urealyticum among students in northern Norway |
Q34298276 | Clinical characteristics associated with Mycoplasma genitalium among female sex workers in Nairobi, Kenya |
Q37119362 | Clinical presentation of Mycoplasma genitalium Infection versus Neisseria gonorrhoeae infection among women with pelvic inflammatory disease |
Q36236663 | Comprehensive assessment of sociodemographic and behavioral risk factors for Mycoplasma genitalium infection in women |
Q36216576 | Correlates of cervical Mycoplasma genitalium and risk of preterm birth among Peruvian women |
Q35543660 | Detection of genital mycoplasmal infections among infertile females by multiplex PCR |
Q88995637 | Does the Sex Risk Quiz Predict Mycoplasma genitalium Infection in Urban Adolescents and Young Adult Women? |
Q36441494 | Epidemiology, pathogenesis and treatment of pelvic inflammatory disease. |
Q38734511 | Expression and characterization of a Mycoplasma genitalium glycosyltransferase in membrane glycolipid biosynthesis: potential target against mycoplasma infections |
Q36098434 | Functional analysis of the Mycoplasma genitalium MG312 protein reveals a specific requirement of the MG312 N-terminal domain for gliding motility |
Q28829569 | Gram-Positive Uropathogens, Polymicrobial Urinary Tract Infection, and the Emerging Microbiota of the Urinary Tract |
Q33875386 | High Mycoplasma genitalium organism burden is associated with shedding of HIV-1 DNA from the cervix |
Q30820940 | Identification and characterization of immunogenic proteins of mycoplasma genitalium. |
Q33797838 | In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains |
Q37490203 | Innate immune mediator profiles and their regulation in a novel polarized immortalized epithelial cell model derived from human endocervix |
Q33482038 | Intracellular Mycoplasma genitalium infection of human vaginal and cervical epithelial cells elicits distinct patterns of inflammatory cytokine secretion and provides a possible survival niche against macrophage-mediated killing |
Q37839814 | Large two-centre study into the prevalence of Mycoplasma genitalium and Trichomonas vaginalis in the Netherlands |
Q26796722 | Management of Mycoplasma genitalium infections - can we hit a moving target? |
Q26798281 | Management of non-gonococcal urethritis |
Q34257355 | Methionine sulfoxide reductase A (MsrA) deficient Mycoplasma genitalium shows decreased interactions with host cells |
Q36854933 | Microbial correlates of delayed care for pelvic inflammatory disease |
Q93104673 | Molecular Testing for Mycoplasma genitalium in the United States: Results from the AMES Prospective Multicenter Clinical Study |
Q40271087 | Multidrug-resistant Mycoplasma genitalium infections in Europe |
Q34956742 | Multiplex PCR testing detection of higher-than-expected rates of cervical mycoplasma, ureaplasma, and trichomonas and viral agent infections in sexually active australian women |
Q42650263 | Mycoplasma genitalium Infection in Adults Reporting Sexual Contact with Infected Partners, Australia, 2008-2016. |
Q34190405 | Mycoplasma genitalium PCR: does freezing of specimens affect sensitivity? |
Q35854916 | Mycoplasma genitalium among adolescent women and their partners |
Q35056772 | Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory disease. |
Q56057553 | Mycoplasma genitalium among young adults in the United States: an emerging sexually transmitted infection |
Q33771940 | Mycoplasma genitalium among young, urban pregnant women |
Q34076727 | Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics |
Q36551175 | Mycoplasma genitalium as a sexually transmitted infection: implications for screening, testing, and treatment |
Q37253442 | Mycoplasma genitalium detected by transcription-mediated amplification is associated with Chlamydia trachomatis in adolescent women |
Q38609855 | Mycoplasma genitalium in Women: Current Knowledge and Research Priorities for This Recently Emerged Pathogen |
Q63752782 | Mycoplasma genitalium incidence, persistence, concordance between partners and progression: systematic review and meta-analysis |
Q37186755 | Mycoplasma genitalium infection among HIV-positive women: prevalence, risk factors and association with vaginal shedding |
Q28083641 | Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis |
Q36192824 | Mycoplasma genitalium infection in women attending a sexually transmitted infection clinic: diagnostic specimen type, coinfections, and predictors |
Q42355223 | Mycoplasma genitalium infections: current treatment options and resistance issues |
Q39293657 | Mycoplasma genitalium is associated with increased genital HIV type 1 RNA in Zimbabwean women |
Q40124458 | Mycoplasma genitalium on the Loose: Time to Sound the Alarm |
Q33613919 | Mycoplasma genitalium rapidly disseminates to the upper reproductive tracts and knees of female mice following vaginal inoculation |
Q43136741 | Mycoplasma genitalium symptoms, concordance and treatment in high-risk sexual dyads |
Q35008363 | Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey |
Q90111635 | Mycoplasma genitalium, a stealth female reproductive tract |
Q40111611 | Mycoplasma genitalium, an agent of reemerging sexually transmitted infections |
Q37099478 | Mycoplasma genitalium-encoded MG309 activates NF-kappaB via Toll-like receptors 2 and 6 to elicit proinflammatory cytokine secretion from human genital epithelial cells |
Q26748959 | Mycoplasma genitalium: An Emerging Sexually Transmitted Infection |
Q26747053 | Mycoplasma genitalium: An Overlooked Sexually Transmitted Pathogen in Women? |
Q51506151 | Mycoplasma genitalium: Is It a Sexually Transmitted Pathogen? |
Q34403627 | Mycoplasma genitalium: a review |
Q35659940 | Mycoplasma genitalium: an emerging cause of pelvic inflammatory disease |
Q21131426 | Mycoplasma genitalium: an emerging cause of sexually transmitted disease in women |
Q36728677 | Mycoplasma genitalium: an emerging sexually transmitted pathogen. |
Q35090137 | Mycoplasma genitalium: from Chrysalis to multicolored butterfly |
Q37136511 | Mycoplasma genitalium: prevalence and behavioural risk factors in the general population |
Q35542157 | Mycoplasma genitalium: should we treat and how? |
Q36571380 | Peptide-based Polyclonal Antibody Production against P110 Protein of Mycoplasma genitalium |
Q34139216 | Prevalence and Treatment Efficacy of Genitourinary Mycoplasmas in Women with Overactive Bladder Symptoms |
Q37833830 | Prevalence and antibiotic resistance of Mycoplasma genitalium among STI clinic attendees in Western Canada: a cross-sectional analysis |
Q35108563 | Prevalence of Mycoplasma genitalium and Mycoplasma hominis in urogenital tract of Brazilian women |
Q37182074 | Prevalence of rectal Trichomonas vaginalis and Mycoplasma genitalium in male patients at the San Francisco STD clinic, 2005-2006 |
Q35922044 | Quantitative Proteomics of the Infectious and Replicative Forms of Chlamydia trachomatis |
Q34269050 | Recent perspectives in the diagnosis and evidence-based treatment of Mycoplasma genitalium |
Q34296045 | Risk factors for Mycoplasma genitalium infection among female sex workers: a cross-sectional study in two cities in southwest China |
Q42689805 | Role of Mycoplasma and ureaplasma species in female lower genital tract infections |
Q37853273 | Sampling for Chlamydia trachomatis infection - a comparison of vaginal, first-catch urine, combined vaginal and first-catch urine and endocervical sampling |
Q34479272 | Sexually transmitted diseases treatment guidelines, 2015. |
Q33355815 | Short tandem repeat sequences in the Mycoplasma genitalium genome and their use in a multilocus genotyping system |
Q37214115 | Simultaneous identification of 14 genital microorganisms in urine by use of a multiplex PCR-based reverse line blot assay |
Q27300779 | Structure-function features of a Mycoplasma glycolipid synthase derived from structural data integration, molecular simulations, and mutational analysis |
Q39369022 | The Immunopathogenesis of Mycoplasma genitalium Infections in Women: A Narrative Review |
Q37858058 | The clinical correlates of genital Chlamydia infection in the era of nucleic acid testing |
Q41046965 | Time to eradication of Mycoplasma genitalium after antibiotic treatment in men and women |
Q39773336 | Transcriptional Profiling of Human Endocervical Tissues Reveals Distinct Gene Expression in the Follicular and Luteal Phases of the Menstrual Cycle |
Q21133562 | Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic |
Search more.